TREA

97473476 - X SCRIBE THERAPEUTICS

Follow

Information

  • Trademark
  • 97473476
  • Serial Number
    97473476
  • Filing Date
    June 23, 2022
    2 years ago
  • Transaction Date
    January 03, 2025
    a month ago
  • Status Date
    June 11, 2024
    8 months ago
  • Published for Opposition Date
    April 25, 2023
    a year ago
  • Location Date
    June 20, 2023
    a year ago
  • Status Code
    731
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    DIBLE, IAN
  • Attorney Docket Number
    333322.20000
    Attorney Name
    John Paul Oleksiuk
    Law Office Assigned Location Code
    M20
  • Owners
Information
Mark Drawing Code
3
Mark Identification
X SCRIBE THERAPEUTICS
Case File Statements
  • DM0000: The mark consists of the stylized wordings "SCRIBE" above "THERAPEUTICS", all to the right of a stylized letter "X" partially formed by horizontal lines displayed atop a circle outline.
  • GS0051: Pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases in human therapeutics, namely, diseases caused by genetic mutations and diseases and disorders for which gene modification would ameliorate or cure; Gene therapy products, namely, biological preparations based on engineered cells for medical use for the treatment of diseases caused by genetic mutations and of diseases and disorders for which gene modification would ameliorate or cure related to immuno-oncology, degenerative disorders, traumatic injury, enzyme replacement therapy, and immunology; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics, namely, for the diagnosis, prevention, and treatment of diseases caused by genetic mutations and of diseases and disorders for which gene modification would ameliorate or cure; Pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders, namely, neurological disorders, Huntington's disease, amyotrophic lateral sclerosis (ALS), front temporal dementia, Alzheimer's, Parkinson's, ataxia, autism, epilepsy, and pain, and also for the prevention and treatment of cardiovascular, peripheral nervous system, endocrine, gastrointestinal, renal, genetic immunological, hepatic, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, respiratory, urogenital, urological, and hematologic diseases and disorders, and cance
  • CC0000: Color is not claimed as a feature of the mark.
  • DS0000: "THERAPEUTICS"
Case File Event Statements
  • 6/27/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 7/12/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/13/2022 - 2 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 3/9/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/16/2023 - a year ago
    5 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/16/2023 - a year ago
    6 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 3/16/2023 - a year ago
    7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 3/16/2023 - a year ago
    8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 3/16/2023 - a year ago
    9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/5/2023 - a year ago
    10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/25/2023 - a year ago
    11 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/25/2023 - a year ago
    12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/20/2023 - a year ago
    13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/10/2023 - a year ago
    14 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/10/2023 - a year ago
    15 - SOU EXTENSION 1 FILED Type: EXT1
  • 12/10/2023 - a year ago
    16 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 12/12/2023 - a year ago
    17 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/11/2024 - 8 months ago
    18 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/15/2024 - 2 months ago
    22 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/2/2025 - a month ago
    23 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA
  • 6/13/2024 - 8 months ago
    21 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/11/2024 - 8 months ago
    20 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 6/11/2024 - 8 months ago
    19 - SOU EXTENSION 2 FILED Type: EXT2